COPENHAGEN (Thomson Financial) - Danish pharmaceutical company Lundbeck AS posted first-quarter EBIT of 924 million Danish crowns, up 40 percent from a year earlier on the back of stronger sales and margins, and significantly ahead of consensus estimates according to RB Boersen for 699 million crowns.
From: www.iii.co.uk
AFX UK Focus) 2008-05-07 07:46 Lundbeck Q1 EBIT beats consensus; reiterates full-year guidance
Posted by Ruslan Abuzant at 12:09 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment